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Edited by Stuart FergusonAbstract The mitochondrial ADP/ATP carriers (AACs) cata-
lyze the exchange of cytosolic ADP for matrix ATP. We have
identiﬁed and characterized a novel member of the AAC subfam-
ily of mitochondrial metabolite transport proteins, termed
AAC4. The AAC4 gene maps to human chromosome 4q28.1,
and its product AAC4 is 66–68% identical to human AAC 1–3
and is localized to mitochondria. AAC4 transcripts are exclu-
sively present in liver, testis and brain unlike those of AAC
1–3. Consistent with its belonging to the AAC subfamily, upon
heterologous expression and reconstitution into liposomes
AAC4 exchanges ADP for ATP by an electrogenic antiport
mechanism with high speciﬁcity and high sensitivity to carboxya-
tractyloside and bongkrekic acid.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The ADP/ATP carrier (AAC) is a nuclear-coded mitochon-
drial protein that catalyzes the exchange of ATP generated in
the mitochondria by ATP-synthase against ADP produced in
the cytosol by most energy consuming reactions (see [1–3]
for reviews). It is therefore essential in oxidative phosphoryla-
tion and in energy metabolism in eukaryotic cells. The AAC
was the ﬁrst membrane carrier protein to be sequenced by Ed-
man degradation [4]; it was the ﬁrst member of the MCF to be
isolated and reconstituted into liposomes [5], to be cloned [6]
and recently to be crystallized in a complex with its speciﬁc
inhibitor carboxyatractyloside [7].
The genome of several organisms including yeast, plants and
mammals contains multiple genes encoding the ADP/ATP
transporter. Three AAC genes have been reported in man thatAbbreviations: AAC, ADP/ATP carrier; BK, bongkrekic acid; CAT,
carboxyatractyloside; BFP, blue ﬂuorescent protein; GFP, green ﬂu-
orescent protein; MCF, mitochondrial carrier family; Pi, phosphate;
PCR, polymerase chain reaction; PIPES, 1,4-piperazinediethanesulf-
onic acid
*Corresponding author. Fax: +39 80 544 2770.
E-mail address: fpalm@farmbiol.uniba.it (F. Palmieri).
0014-5793/$30.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.12.034encode diﬀerent isoforms of the proteins (see [3] for a review).
These isoforms have diﬀerent tissue distribution: AAC1 is
known to be speciﬁc to heart and skeletal muscle, AAC2 to
be present in proliferating cells and AAC3 to be ubiquitous
[8]. Furthermore, diﬀerent patterns of distribution of the
AAC isoform mRNAs have been observed in diﬀerent stages
of cell diﬀerentiation, in response to growth conditions and
metabolic inhibitors, and in certain pathologies such as cancer
and myopathies (see [9] for references). In addition, some hu-
man diseases have been associated with AAC1 deﬁciency (see
[3] for references).
Here, we report the identiﬁcation and characterization of an
additional member of the MCF, termed AAC4, which shows
68% identical amino acids to the original AAC sequence
(AAC1 encoded by SLC25A4).2. Materials and methods
2.1. Sequence search and analysis
The human genome at the NCBI was screened with the sequence of
the human AAC1 protein (NM_001151) with TBLASTN. The amino
acid sequences were aligned with ClustalW (version 1.7).
2.2. Construction of the expression plasmids
The coding sequence for AAC4 was ampliﬁed from human liver
cDNA by PCR with nucleotides 128–145 and 1044–1076 of the cDNA
sequence (NM_031291) as primers. The product was cloned into the
pET 21-b vector and the construct was transformed into E. coli TOP
10 cells. Transformants were selected and screened. The protein was
overproduced as inclusion bodies in E. coli BL-21 CodonPlus (DE3)-
RIL. Inclusion bodies were isolated and AAC4 was puriﬁed by centri-
fugation and washing steps as described [10].
2.3. Reconstitution into liposomes and transport assays
The recombinant protein in sarkosyl was reconstituted into lipo-
somes in the presence of substrates as described before [11]. External
substrate was removed on Sephadex G-75. Transport at 25 C was
started by adding [14C]ADP (from NEN) or [14C]ATP (from Amer-
sham) to proteoliposomes and terminated by addition of 30 mM pyr-
idoxal 5 0-phosphate and 20 mM bathophenanthroline. In controls,
inhibitors were added with the labeled substrate. 10 mM PIPES, pH
7.0, was present inside and outside the proteoliposomes, except where
otherwise indicated. Finally, entrapped radioactivity was counted [11].
Eﬄux of substrate from proteoliposomes containing 2 mM [14C]ADP
was performed as described [11].2.4. Expression analysis by real-time PCR
Total RNAs from human tissues (Invitrogen) were reverse-tran-
scribed with the GeneAmp RNA PCR Core kit with random hexamers
as primers. For real-time PCRs, primers and probes based on theblished by Elsevier B.V. All rights reserved.
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(Applied Biosystems). Real-time PCRs were performed as described
previously [12]. To correct for diﬀerences in the amount of starting
ﬁrst-stranded cDNAs, the human b-actin gene was ampliﬁed in parallel
as a reference gene. The relative quantiﬁcation of AAC mRNAs in var-
ious tissues was performed according to the comparative method
(2DDCt) (see [12]). 2DDCt ¼ 2ðDCtsampleDCtcalibratorÞ, where DCt sample
is Ct sample  Ct reference gene, and Ct is the threshold cycle.
2.5. Other methods
Proteins were analyzed by SDS–PAGE and stained with Coomassie
Blue dye. The N-terminus was sequenced and the amount of puriﬁed
AAC4 was estimated by laser densitometry [12]. The amount of pro-
tein incorporated into liposomes was measured as described [12]. It
was about 20% of the protein added to the reconstitution mixture.
K+-diﬀusion potentials or pH gradients were generated using valino-
mycin or nigericin and a K+ gradient of 1/50 (mM/mM, in/out) as de-
scribed [12]. The intracellular localization of AAC4 fused to GFP in
CHO (Chinese-hamster ovary) cells was performed as described [12].3. Results and discussion
3.1. Identiﬁcation of the AAC4 cDNA
By screening human non-redundant databases with the hu-
man AAC1 sequence (NM_001151), three unknown clones
(NM_031291, AL136857 and BC022032) were found. They
had the same open reading frame of 945 bp encoding a mem-
ber of the MCF [3]. This previously unidentiﬁed transporter
protein, named AAC4, shares 66–68% of identical amino acids
with the three known human isoforms of the AAC (Fig. 1).
AAC4 contains the RRRMMM motif characteristic of the
mitochondrial AAC protein subfamily. A major diﬀerence be-
tween human AAC 1–3 (which share 88–92% of identical ami-
no acids) and AAC4 is that the charged residues are very
diﬀerently distributed along the polypeptide chain. In fact,
the great majority of charge residue mutations of AAC4 with
respect to AAC 1–3 is substituted in a non-conservative man-
ner (at least 24 out of 28), whereas only one of this type of
mutations among AAC 1–3 (3–5 in total) is non-conservative.
The residues implicated in carboxyatractyloside binding (andFig. 1. Alignment of the four human AAC isoforms. The asterisks indicate
accession numbers are NM_001151(AAC1), NM_001152(AAC2), XN_1147possibly in cytosolic ADP binding), as revealed by the crystal-
lographic structure of the bovine AAC1-carboxyatractyloside
complex [7], are all conserved. The residues E264 and R236,
which in the X-ray structure form a salt bridge, are also con-
served. It has been suggested that the matrix ATP destabilizes
this salt bridge causing a reorientation of E264 that would im-
pede external nucleotide binding and would favor matrix ATP
interaction with the glutamate via its adenine or ribose moiety
and with K267 or K271 via the phosphate groups [7]. How-
ever, in AAC4 K267 is substituted by a serine residue (S278)
and K271 by a conservative arginine (R282). Another diﬀer-
ence between AAC4 and AAC1 is the substitution of R104
with a lysine residue (K117). In the X-ray structure of the bo-
vine AAC1, R104 contributes to the cationic cluster that is lo-
cated near the entrance of the large cavity containing CAT and
is thought to participate in attracting the substrate towards its
binding site [7].
Among protein sequences of unknown function from other
organisms, AAC4 shows a high degree of identical amino acids
with AAH50810 from Mus musculus (87% identity) and
XM_215549 from Rattus norvegicus (84% identity). Therefore,
these proteins are likely orthologs of AAC4.
The AAC4 gene (named SLC25A31) is spread over about 43
kb of the human genome, contains six exons and is localized
on chromosome 4q28.1.
3.2. Bacterial expression and functional characterization of
AAC4
The AAC4 gene was overexpressed in E. coli and AAC4 was
puriﬁed as a single band of about 35 kDa on SDS–PAGE (not
shown). Its identity was conﬁrmed by N-terminal sequencing.
The recombinant AAC4 was reconstituted into liposomes
and its transport activity for a variety of potential substrates
was tested. High activities of [14C]ADP uptake into proteolipo-
somes were observed with internal ADP, ATP, dADP and
dATP (Fig. 2). In contrast, virtually no uptake of [14C] ADP
was found with internal AMP, dAMP, GTP, GDP, CTP,
CDP, TTP, TDP, UTP, UDP, Pi, pyrophosphate and (notidentities, while conservative substitutions are shown by the dots. The
24 (AAC3) and AJ863129 (AAC4).
Fig. 2. Dependence of AAC4 activity on internal substrate. Proteo-
liposomes were pre-loaded internally with various substrates (10 mM).
Transport was started by adding 50 lM [14C]ADP to proteoliposomes
reconstituted with AAC4 and stopped after 1 min. Similar results were
obtained in at least three independent experiments.
Fig. 3. Kinetics of [14C]ADP transport in proteoliposomes reconsti-
tuted with AAC4. (A) Uptake of ADP. 0.5 mM [14C]ADP was added
to proteoliposomes containing 5 mM ADP (exchange, d) or 5 mM
NaCl and no substrate (uniport,s). (B) Eﬄux of [14C]ADP. The eﬄux
of [14C]ADP was started by adding 50 mM NaCl and 10 mM PIPES,
pH 7.0, with 5 mM ADP () or without ADP (j). Similar results were
obtained in three independent experiments.
Table 1
Inﬂuence of membrane potential and DpH on the activity of
reconstituted AAC4
Uptake of Internal
substrate
Transport activity (lmol/min/g protein)
Control +valinomycin +nigericin
[14C]ADP ATP 504 240 487
ADP 530 518 515
[14C]ATP ADP 506 777 531
ATP 545 559 550
Transport was started by adding either 70 lM [14C]ADP or 100 lM
[14C]ATP together with 50 mMKCl to preoteoliposomes containing 10
mM substrate and 1 mM KCl. Reaction time: 1 min. 1 mM PIPES-
NaOH at pH 7.0 was present in the internal and external compart-
ments. Similar results were obtained in three independent experiments.
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adenosine, adenine, NMN, FMN, thiamine pyrophosphate,
NAD, FAD, coenzyme A, citrate and oxoglutarate. Moreover,
no ADP/ADP homoexchange was detected with AAC4 that
had been boiled before incorporation into liposomes (not
shown). These results demonstrate that AAC4 displays a very
high substrate speciﬁcity similar to that of the AAC [1,2].
The AAC is characterized by a high and speciﬁc sensitivity
to CAT and BK [1,2]. The AAC4-mediated ADP/ADP ex-
change reaction was inhibited strongly by 10 lM CAT or 10
lM BK when used separately and completely when used
together (Fig. 2). This behavior is the same as that determined
for the AAC [1,2] and diﬀerent from that shown by the more
recently identiﬁed members of the MCF that also transport
nucleotides [12–15].
In Fig. 3A, the kinetics are compared for the uptake by pro-
teoliposomes of 0.5 mM [14C]ADP in the presence and absence
of internal ADP. The uptake of ADP by exchange followed a
ﬁrst-order kinetics (rate constant 0.1 min1; initial rate 0.91
mmol/min/g protein). In contrast, no [14C]ADP uptake was
observed without internal substrate, suggesting that AAC4
does not catalyze a unidirectional transport of ADP. This
was conﬁrmed by measuring the eﬄux of [14C]ADP from
pre-labeled proteoliposomes (Fig. 3B). Without external sub-
strate, no eﬄux was observed even after incubation for 90
min. However, upon addition of ADP, an extensive eﬄux of
radioactivity occurred. These results show that reconstituted
AAC4 catalyzes an obligatory antiport mechanism, as shown
previously for the AAC [1,2].
The exchange rate of internal ADP or ATP (10 mM) de-
pended on the external concentration of [14C]ADP or
[14C]ATP (18–2000 lM). For ADP and ATP, the transport
aﬃnities (Km) were 72 ± 8 and 120 ± 13 lM, respectively.
The average value of Vmax for both ADP/ADP and ATP/
ATP exchanges was 1.3 ± 0.2 mmol/min per gram of protein.
The Km values of AAC4 for ADP and ATP are much higher
than those of human AAC 1–3, as determined upon heterolo-
gous expression in a yeast mutant lacking the three endoge-nous AACs [16]. It is interesting that in rat liver
mitochondria, where the contribution of AAC4 to the total
AAC content is signiﬁcant with respect to the other AAC iso-
forms (see below), two Km values for both ADP and ATP dif-
fering by a factor of about 4 (ADP) or 10 (ATP) were
evaluated and the higher Kms pertain to about 30–80% of
the maximal activity [1]. In heart mitochondria, where AAC4
is absent (see below), there was only one Km for both ADP
and ATP [1].
Since the AAC has been shown to catalyze an electropho-
retic exchange between ADP3 and ATP4, we investigated
the inﬂuence of the membrane potential on the exchanges cat-
alyzed by AAC4. In the presence of a Dw of about 100 mV po-
sitive inside, the rates of the [14C]ATPout/ADPin and
[14C]ADPout/ATPin exchanges were stimulated and decreased,
Fig. 4. Subcellular localization of human AAC4. CHO cells were
transiently co-transfected with pcDNA3 vector carrying the DNA
sequence coding AAC4 in frame with GFP DNA sequence and
pcDNA1 plasmid carrying the DNA sequence of mitochondrially
targeted BFP. AAC4-GFP, ﬂuorescence of GFP fused to AAC4; mt-
BFP, ﬂuorescence of the mtBFP (here shown in red); overlay, merged
image of mtBFP ﬂuorescence with AAC4-GFP ﬂuorescence. Images
were acquired by a ﬂuorescence microscope equipped with appropriate
ﬁlters and identical ﬁelds are presented.
Fig. 5. Expression of AAC isoform genes in human tissues. The
relative quantiﬁcation of AAC 1–4 mRNA (A) or AAC4 mRNA (B) in
the indicated tissues was performed according to the comparative
method (see Section 2). In (B) the brain DCt for AAC4 mRNA was
used as an internal calibrator, whereas in (A) the pancreas DCt for
AAC1 mRNA, the kidney DCt for AAC2 mRNA, the spleen DCt for
AAC3 mRNA and the liver DCt for AAC4 mRNA were used as
internal calibrators. For the internal calibrator, the DDCt equals zero
and 20 equals one. For the remaining tissues, the value of 2DDCt
indicates the fold change in gene expression relative to the calibrator.
The relative amounts of mRNA are shown in red (AAC1), green
(AAC2), yellow (AAC3) and black (AAC4). The data are means of
three independent experiments.
636 V. Dolce et al. / FEBS Letters 579 (2005) 633–637respectively (Table 1). In the absence of Dw or when homoex-
changes were measured, no eﬀect was observed. Therefore, the
AAC4-mediated ADP/ATP exchange is electrophoretic and
hence the AAC4 is also similar in this respect to the AAC
[1,2]. However, the pH gradient (basic inside) created by nige-
ricin and the K+ gradient did not aﬀect the ADP/ATP hetero-
exchange as well as the homoexchanges (Table 1), which
contrasts with the results obtained with recently identiﬁed
mitochondrial nucleotide transporters, that catalyze an elec-
troneutral H+-compensated substrate exchange [12,14,15].
3.3. Subcellular localization of AAC4
Since some members of the MCF are localized in non-mito-
chondrial membranes [15], the intracellular localization of ex-
pressed AAC4 was investigated using a GFP-fused protein
(Fig. 4). After 36–48 h transfection, the green ﬂuorescence re-
vealed a typical mitochondrial localization of AAC4, and the
ﬂuorescence of the GFP-tagged protein completely overlapped
with the blue ﬂuorescence of a mitochondrially targeted BFP
co-expressed in the same cells. Therefore, AAC4 localizes to
mitochondria.
3.4. Expression of the AAC4 gene in human tissues
The tissue distribution of mRNAs for AAC 1–4 determined
for the ﬁrst time by real-time PCR is summarized in Fig. 5. The
amount of AAC4 mRNA in liver was the same as that of
AAC1, AAC2 and AAC3 mRNA in pancreas, kidney and
spleen (as they have the same DCt in these tissues), and so this
value served as an internal calibration in the relative quantiﬁ-
cation of these proteins in various tissues. As shown in Fig.
5A, the AAC4 gene was expressed in liver at levels comparable
to those of the other AAC genes and in testis at lower levels
than the others. The AAC1 gene was expressed abundantly
in heart and skeletal muscle, but we found that it was also ex-
pressed strongly in lung and testis and in lower amounts in
brain, kidney, liver, pancreas and small intestine; the AAC2
gene was expressed at higher levels in lung, testis and small
intestine and less in kidney, liver and pancreas; and the
AAC3 gene was expressed ubiquitously but in very abundant
amounts in lung and testis and strongly in pancreas and small
intestine. It is noteworthy that if the DCt of AAC4 mRNA in
brain is used as an internal calibrator in the relative quantiﬁca-
tion of AAC4 mRNA, it is clear that this was also present in
extremely low amounts in brain (Fig. 5B), whereas it was notdetectable in any of the other tissues tested (not shown). It
should also be noted that, as post-transcriptional mechanisms
may operate, the levels of expression presented in Fig. 5 do not
necessarily reﬂect the ratios of transport activities.
Since human cells express more than one AAC gene simulta-
neously, the elucidation of the speciﬁc role played by AAC4
and each of the other isoforms remains to be ascertained in
further investigations.
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